NKTR — Nektar Therapeutics
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Nektar Therapeutics (NKTR), worth $48.63M combined. Over the quarter 2 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Emerald | $27.24M | 0.64% | -1.1% |
| Emerald Mutual | $17.84M | 0.63% | -0.2% |
| IMC | $1.56M | 0.01% | +37% |
| BIT | $1.47M | 0.05% | NO CHANGE |
| Persistent | $522.25K | 0.16% | +28.5% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.